WallStreetZenWallStreetZen

NASDAQ: EDIT
Editas Medicine Inc Stock Ownership - Who owns Editas Medicine?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Editas Medicine Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amy ParisonSVP Chief Financial Officer2025-09-03458$2.60
$1.19kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-09-03710$2.60
$1.84kSell
Gilmore Neil OneillCEO2025-09-035,592$2.60
$14.52kSell
Amy ParisonSVP Chief Financial Officer2025-08-07679$2.58
$1.75kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-07-315,121$2.49
$12.76kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-06-03726$1.72
$1.25kSell
Amy ParisonSVP Chief Financial Officer2025-06-03446$1.72
$768.90Sell
Gilmore Neil OneillCEO2025-06-0315,192$1.72
$26.19kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-03-042,891$1.71
$4.95kSell
Erick LuceraEVP CHIEF FINANCIAL OFFICER2025-03-044,109$1.71
$7.03kSell

1 of 2

EDIT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EDIT insiders and whales buy or sell their stock.

EDIT Shareholders

What type of owners hold Editas Medicine Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc7.96%7,159,492$19.26MInstitution
Blackrock Inc7.59%6,820,854$18.35MInstitution
Kevin P. Starr4.34%3,906,176$10.51MInsider
Third Rock Ventures III LP4.34%3,906,176$10.51MInsider
Polaris Venture Management Co VI LLC4.22%3,797,144$10.21MInsider
Viking Global Investors LP3.33%2,996,590$8.06MInsider
Kevin Bitterman3.11%2,797,144$7.52MInsider
Flagship Ventures Fund IV LP3.10%2,786,967$7.50MInsider
Boris Nikolic2.99%2,684,572$7.22MInsider
Bng0 LLC2.95%2,649,572$7.13MInsider

1 of 3

EDIT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EDIT45.97%36.66%Net SellingNet Selling
FENC3.80%96.20%Net SellingNet Buying
ACIU24.40%0.00%
QSI31.75%49.32%Net SellingNet Selling
IMMP0.12%0.00%
View Top Biotech Stocks

Editas Medicine Stock Ownership FAQ

Who owns Editas Medicine?

Editas Medicine (NASDAQ: EDIT) is owned by 45.97% institutional shareholders, 36.66% Editas Medicine insiders, and 17.37% retail investors. Kevin P. Starr is the largest individual Editas Medicine shareholder, owning 3.91M shares representing 4.34% of the company. Kevin P. Starr's Editas Medicine shares are currently valued at $10.51M.

If you're new to stock investing, here's how to buy Editas Medicine stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.